About this Episode
In this episode we speak with Pam Mace, Patient, Executive Director and Co-founder of the Fibromuscular Dysplasia Society of America.
Without a cure, this patient advocate collaborated with researchers from Mt. Sinai, and the Victor Chang Cardiac Research Institute and catalyzed a growing patient advocacy movement that drives information exchange, physician education, and data collection.
WCG is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two divisions, the industry’s first central IRB – WCG IRB – and first clinical services organization, WCG enables biopharmaceutical companies, CROs, and institutions to advance the delivery of new treatments and therapies to patients, while maintaining the highest standards of human participant protection. For more information, please visit www.wcgirb.com, www.wcgclinical.com or follow us on Twitter @WCGClinical or LinkedIn.